Cyclophilin A in Arrhythmogenic Cardiomyopathy Cardiac Remodeling
Erica Rurali1, Chiara Assunta Pilato2, Gianluca Lorenzo Perrucci3
1Unit of Vascular Biology and Regenerative Medicine, Centro Cardiologico Monzino IRCCS, 20138 Milano, Italy. erica.rurali@ccfm.it.
Insights
Cyclophilin A (CyPA) is elevated in arrhythmogenic cardiomyopathy (ACM) patients, correlating with fibro-fatty tissue. This protein is upregulated during cardiac mesenchymal stromal cell (C-MSC) adipogenesis, suggesting a role in ACM remodeling.
Area of Science:
- Cardiovascular Biology
- Genetic Disorders
- Cellular Pathophysiology
Background:
- Arrhythmogenic cardiomyopathy (ACM) involves fibro-fatty tissue replacement in the myocardium, leading to arrhythmias and sudden death.
- Cyclophilin A (CyPA) is implicated in fibrosis, inflammation, and adipogenesis, processes relevant to ACM.
- The role of CyPA in ACM cardiac remodeling remains unexplored.
Purpose of the Study:
- To investigate Cyclophilin A (CyPA) expression in arrhythmogenic cardiomyopathy (ACM) cardiac remodeling.
- To assess CyPA modulation in ACM-derived cardiac mesenchymal stromal cells (C-MSCs) during adipogenesis.
Main Methods:
- Immunohistochemistry was used to evaluate RV tissue from ACM patients and healthy controls (HC).
- ACM- and HC-derived C-MSCs were utilized to study CyPA expression and secretion during adipogenic differentiation.
Main Results:
- CyPA expression was significantly higher in the right ventricle (RV) of ACM patients compared to HC.
- Elevated CyPA levels in ACM correlated with the extent of adipose tissue replacement.
- CyPA was upregulated during early adipogenic differentiation of C-MSCs and secreted at higher levels by ACM-derived C-MSCs.
Conclusions:
- This study reveals increased CyPA expression in ACM cardiac tissue and its upregulation during adipogenesis.
- Findings suggest CyPA plays a role in ACM-associated cardiac remodeling.
- Provides a basis for future C-MSC-based research into ACM mechanisms and therapies.
Abstract:
Arrhythmogenic cardiomyopathy (ACM) is a genetic disorder characterized by the progressive substitution of functional myocardium with noncontractile fibro-fatty tissue contributing to ventricular arrhythmias and sudden cardiac death. Cyclophilin A (CyPA) is a ubiquitous protein involved in several pathological mechanisms, which also characterize ACM (i.e., fibrosis, inflammation, and adipogenesis). Nevertheless, the involvement of CyPA in ACM cardiac remodeling has not been investigated yet. Thus, we first evaluated CyPA expression levels in the right ventricle (RV) tissue specimens obtained from ACM patients and healthy controls (HC) by immunohistochemistry. Then, we took advantage of ACM- and HC-derived cardiac mesenchymal stromal cells (C-MSC) to assess CyPA modulation during adipogenic differentiation. Interestingly, CyPA was more expressed in the RV sections obtained from ACM vs. HC subjects and positively correlated with the adipose replacement extent. Moreover, CyPA was upregulated at early stages of C-MSC adipogenic differentiation and was secreted at higher level over time in ACM- derived C-MSC. Our study provides novel ex vivo and in vitro information on CyPA expression in ACM remodeling paving the way for future C-MSC-based mechanistic and therapeutic investigations.
Related Concept Videos
Nucleosome Remodeling
Nucleosome remodeling complex
Eukaryotic cells have specialized enzymes called ATP-dependent nucleosome remodeling enzymes. These enzymes...
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy IV: Restrictive Cardiomyopathy
Bone Remodeling
Cardiomyopathy V: Interprofessional Care


